164 related articles for article (PubMed ID: 31118237)
1. Activation of the ILT7 receptor and plasmacytoid dendritic cell responses are governed by structurally-distinct BST2 determinants.
Bego MG; Miguet N; Laliberté A; Aschman N; Gerard F; Merakos AA; Weissenhorn W; Cohen ÉA
J Biol Chem; 2019 Jul; 294(27):10503-10518. PubMed ID: 31118237
[TBL] [Abstract][Full Text] [Related]
2. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.
Cao W; Bover L; Cho M; Wen X; Hanabuchi S; Bao M; Rosen DB; Wang YH; Shaw JL; Du Q; Li C; Arai N; Yao Z; Lanier LL; Liu YJ
J Exp Med; 2009 Jul; 206(7):1603-14. PubMed ID: 19564354
[TBL] [Abstract][Full Text] [Related]
3. Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells.
Cao W; Bover L
Immunol Rev; 2010 Mar; 234(1):163-76. PubMed ID: 20193018
[TBL] [Abstract][Full Text] [Related]
4. Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes.
Tavano B; Galao RP; Graham DR; Neil SJ; Aquino VN; Fuchs D; Boasso A
J Immunol; 2013 Mar; 190(6):2622-30. PubMed ID: 23401591
[TBL] [Abstract][Full Text] [Related]
5. Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains.
Bego MG; Cong L; Mack K; Kirchhoff F; Cohen ÉA
J Virol; 2016 Nov; 90(22):10236-10246. PubMed ID: 27581991
[TBL] [Abstract][Full Text] [Related]
6. Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.
Bego MG; Côté É; Aschman N; Mercier J; Weissenhorn W; Cohen ÉA
PLoS Pathog; 2015 Jul; 11(7):e1005024. PubMed ID: 26172439
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoids dendritic cells are a therapeutic target in anticancer immunity.
Palma G; De Laurenzi V; De Marco M; Barbieri A; Petrillo A; Turco MC; Arra C
Biochim Biophys Acta; 2012 Dec; 1826(2):407-14. PubMed ID: 22579960
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of the host restriction factor tetherin in viral immune sensing.
Hotter D; Sauter D; Kirchhoff F
J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
[TBL] [Abstract][Full Text] [Related]
9. BST2/Tetherin is constitutively expressed on human thymocytes with the phenotype and function of Treg cells.
Epeldegui M; Blom B; Uittenbogaart CH
Eur J Immunol; 2015 Mar; 45(3):728-37. PubMed ID: 25408362
[TBL] [Abstract][Full Text] [Related]
10. Effect of immunoglobin-like transcript 7 cross-linking on plasmacytoid dendritic cells differentiation into antigen-presenting cells.
Tavano B; Boasso A
PLoS One; 2014; 9(2):e89414. PubMed ID: 24586760
[TBL] [Abstract][Full Text] [Related]
11. SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production.
Cho M; Ishida K; Chen J; Ohkawa J; Chen W; Namiki S; Kotaki A; Arai N; Arai K; Kamogawa-Schifter Y
Int Immunol; 2008 Jan; 20(1):155-64. PubMed ID: 18048391
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.
Cao W; Rosen DB; Ito T; Bover L; Bao M; Watanabe G; Yao Z; Zhang L; Lanier LL; Liu YJ
J Exp Med; 2006 Jun; 203(6):1399-405. PubMed ID: 16735691
[TBL] [Abstract][Full Text] [Related]
13. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
14. Impairment of plasmacytoid dendritic cells for IFN production by the ligand for immunoglobulin-like transcript 7 expressed on human cancer cells.
Tsukamoto N; Okada S; Onami Y; Sasaki Y; Umezawa K; Kawakami Y
Clin Cancer Res; 2009 Sep; 15(18):5733-43. PubMed ID: 19723650
[TBL] [Abstract][Full Text] [Related]
15. Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1.
Zhao Y; Zhao K; Wang S; Du J
Front Cell Infect Microbiol; 2022; 12():979091. PubMed ID: 36176574
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.
Tiberio L; Laffranchi M; Zucchi G; Salvi V; Schioppa T; Sozzani S; Del Prete A; Bosisio D
Front Immunol; 2024; 15():1360291. PubMed ID: 38504978
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of plasmacytoid dendritic cells and Toll-like receptor-9 regarding the treatment efficacy of interferon-α in HBeAg-positive chronic hepatitis B patients.
Chen Y; Yang JE; Tang JM; Mao QG; Zheng QZ; Zheng Y
Exp Ther Med; 2019 Dec; 18(6):4541-4546. PubMed ID: 31798696
[TBL] [Abstract][Full Text] [Related]
18. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
Yu H; Bian Q; Wang X; Wang X; Lai L; Wu Z; Zhao Z; Ban B
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240088
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
